Rang	Name	Position
1	Mr. Eric Blasius Risser	CEO, President & Director
2	Mr. James Karrels	Senior VP & CFO
3	Dr. Ezio Bonvini M.D.	Senior VP of Research & Chief Scientific Officer
4	Dr. Araba Lamouse-Smith Ph.D.	Vice President of Technical Operations
5	Mr. Jeffrey Stuart Peters J.D.	Senior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer
6	Mr. Steve Harig	Senior Vice President of Human Resources
7	Mr. Harish Krishnaswamy	Senior Vice President of Business Development & Portfolio Planning
8	Dr. Frank George Perabo FEBU, M.D., Ph.D.	Vice President & Interim Head of Clinical Development
9	Ms. Beth Smith	VP, Controller & Treasurer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Armistice Capital, LLC	9,46%	24,10 Mio. USD
2	Renaissance Technologies Corp	4,66%	11,88 Mio. USD
3	Vanguard Capital Management, LLC	4,18%	10,64 Mio. USD
4	Acadian Asset Management LLC	4,00%	10,20 Mio. USD
5	Two Sigma Investments LLC	3,88%	9,88 Mio. USD
6	Bank of America Corp	3,78%	9,63 Mio. USD
7	Millennium Management LLC	3,74%	9,52 Mio. USD
8	Marshall Wace Asset Management Ltd	3,19%	8,12 Mio. USD
9	Wasatch Advisors LP	3,18%	8,09 Mio. USD
10	RA Capital Management, LLC	2,93%	7,47 Mio. USD
11	Affinity Asset Advisors, LLC	1,91%	4,88 Mio. USD
12	Vanguard Portfolio Management, LLC	1,90%	4,85 Mio. USD
13	BlackRock Inc	1,83%	4,66 Mio. USD
14	D. E. Shaw & Co LP	1,67%	4,26 Mio. USD
15	Connor Clark & Lunn Inv Mgmt Ltd	1,36%	3,48 Mio. USD
16	Geode Capital Management, LLC	1,10%	2,80 Mio. USD
17	Jane Street Group LLC	0,96%	2,44 Mio. USD
18	Mackenzie Investments	0,94%	2,40 Mio. USD
19	Susquehanna International Group, LLP	0,71%	1,81 Mio. USD
20	Jacobs Levy Equity Management, Inc.	0,69%	1,77 Mio. USD